The Andhra Pradesh cabinet approves two engineering projects worth Rs 2,723 crore for Amaravati, including a green ammonia manufacturing facility and South India's first integrated energy project.

Oysters harvested from December 2 to December 17 by Ruco’s Shellfish from a portion of Hammersley Inlet growing area in Washington state were potentially contaminated, the FDA said in a Thursday ...

This is the FDA's fourth oyster recall in three weeks, reflecting an alarming increase in norovirus outbreaks across the nation. The U.S. Centers for Disease Control and Prevention (CDC ...

Being approved for a credit card isn’t always easy, especially if you have bad credit or none at all. You aren’t born with a credit score stamped on your credit report. It’s something that you earn, ...

Japan approves SIGA's TEPOXX, the first antiviral for orthopoxviruses, for smallpox, mpox, cowpox, and vaccine-related complications. Approval is based on 15 clinical trials and pivotal animal ...

Almost exactly 10 years after the FDA’s initial FDA approval for Bristol Myers Squibb’s Opdivo as the first PD-1 inhibitor in the U.S., the agency has cleared an under-the-skin version of the ...

Subcutaneous nivolumab and hyaluronidase-nvhy is FDA-approved for adult solid tumors, offering a new administration route for PD-1 inhibitors. The phase 3 CheckMate-67T trial confirmed ...

Ryoncil, the first mesenchymal stromal cell therapy, showed a 70% overall response rate in pediatric steroid-refractory acute GVHD, with a median DOR of 54 days. The FDA approved several drugs in ...

The FDA’s Center for Drug Evaluation and Research (CDER) approved 50 new small molecules, biologics and oligonucleotide therapeutics last year. The class of 2024 was a little smaller than that ...

The Food and Drug Administration (FDA) on Dec. 20 approved the obesity medication Zepbound (tirzepatide) as the first pharmaceutical treatment for moderate-to-severe obstructive sleep apnea (OSA) in ...

Rich Scherr is a seasoned journalist and editor who has traveled across the U.S., Canada, and Europe, and spent more than a decade reviewing hotel room.

New chemotherapy-free treatment shows promise for EGFR-mutated NSCLC Janssen-Cilag International NV, a Johnson & Johnson company, announced that the European Commission has approved Rybrevant ...